ArticleNature communications2025
Mode conversion of hyperbolic phonon polaritons in van der Waals terraces.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Electromagnetic hyperbolicity has driven key functionalities in nanophotonics, including super-resolution imaging, efficient energy control, and extreme light manipulation. Central to these advances are hyperbolic polaritons-nanometer-scale light-matter waves-spanning multiple energy-momentum dispersion orders with distinct mode profiles and incrementally high optical momenta. In this work, we report the mode conversion of hyperbolic polaritons across different dispersion orders by breaking the structure symmetry in engineered step-shape van der Waals (vdW) terraces. The mode conversion from the fundamental to high-order hyperbolic polaritons is imaged using scattering-type scanning near-field optical microscopy (s-SNOM) on both hexagonal boron nitride (hBN) and alpha-phase molybdenum trioxide (α-MoO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.